Prothrombin is the precursor of thrombin, a central enzyme in coagulation.
Autoantibodies to prothrombin are associated with thromboembolism, but the
mechanisms by which the antibodies modulate the coagulation processes are n
ot understood. We screened a panel of 34 monoclonal antibody light chains i
solated from patients with multiple myeloma for prothrombinase activity by
an electrophoresis method. Two light chains with the activity were identifi
ed, and one of the light chains was characterized further. The prothrombina
se activity eluted from a gel-filtration column run in denaturing solvent (
6 M guanidine hydrochloride) at the characteristic positions of the light c
hain dimer and monomer. A constant level of catalytic activity was observed
across the width of the light chain monomer peak, assessed as the cleavage
of IEGR-methylcoumarinamide, a peptide substrate corresponding to residues
268-271 of prothrombin. Hydrolysis of this peptide by the light chain was
saturable and consistent with Michaelis-Menten-Henri kinetics (K-m 103 mu M
; k(cat) of 2.62 x 10(-2)/min). Four cleavage sites in prothrombin were ide
ntified by N-terminal sequencing of the fragments: Arg(155)-Ser(156), Arg(2
71)-Thr(272), Arg(284)-Thr(285), and Arg(393)-Ser(394). The light chain did
not cleave radiolabeled albumin, thyroglobulin, and annexin V under condit
ions that readily permitted detectable prothrombin cleavage. Two prothrombi
n fragments (M-r 55 000 and 38 000), were isolated by anion-exchange chroma
tography and were observed to cleave a thrombin substrate, tosyl-GPR-nitroa
nilide. Conversion of fibrinogen to fibrin was accelerated by the prothromb
in fragments generated by the light chain. These finding suggest a novel me
chanism whereby antibodies can induce a procoagulant state, i.e., prothromb
in activation via cleavage of the molecule.